Maria Velkova is a Managing Partner at Tabula Rasa Ventures (TRV), a pioneering investment firm building the future of human health – defined as holistic, personalized, preventative, and democratized, underpinned by rigorous scientific and clinical evidence.

Maria is a seasoned biopharma executive with 10+ years of experience developing and implementing global drug strategy for top pharma companies like Roche, AstraZeneca, Novartis, and more. Her expertise bridges the silos in drug development and spans across R&D, clinical trial design, product launch, regulatory affairs, business intelligence, sales, operations and M&A.
Maria is recognized as one of the top 15 Global Psychedelics Executives, has led high profile events at Davos, alongside the World Economic Forum, and pioneered education on psychedelic therapeutics in the Arab Region.
Maria holds a degree in BSc Pharmacology from Leeds University and MPhil in Bioscience Enterprise from Cambridge University, where she was a visiting lecturer in 2016.

Maria is passionate about shaping the future landscape of healthcare and helping companies steer successfully in bringing true health innovations to all patients.